Theravance Biopharma, Inc. (TBPH)
19.16
-0.24
(-1.24%)
USD |
NASDAQ |
Feb 11, 12:12
Theravance Biopharma Market Cap : 970.88M for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.225B |
| Nektar Therapeutics | 1.131B |
| Innoviva, Inc. | 1.635B |
| Oramed Pharmaceuticals, Inc. | 128.96M |
| Skye Bioscience, Inc. | 23.18M |
Market Cap Related Metrics
| PE Ratio | 34.06 |
| PS Ratio | 12.02 |
| Price to Book Value | 4.173 |
| Price to Free Cash Flow | 3.967 |
| Price | 19.16 |
| Earnings Yield | 2.94% |
| Normalized PE Ratio | 34.06 |